SCHEMBL3662394

SCHEMBL3662394

[O]c1ccc(-c2coc3cc(OCc4coc(-c5cc(F)cc(C(F)(F)F)c5)n4)ccc3c2=O)cc1

nearest known ligand 0.48

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH2 P05091 20/20 0.48
MAOA P21397 12/20 0.48
MAOB P27338 12/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2108174 0.93 ALDH2 (0.57) ALDH2MAOAMAOB
SCHEMBL2108388 0.90 ALDH2 (0.47) ALDH2MAOAMAOB
SCHEMBL3623551 0.89 ALDH2 (0.44) ALDH2MAOAMAOB
SCHEMBL2110551 0.88 ALDH2 (0.43) ALDH2MAOAMAOB
SCHEMBL2107867 0.88 ALDH2 (0.45) ALDH2MAOAMAOB
SCHEMBL2109138 0.87 ALDH2 (0.42) ALDH2MAOAMAOB
SCHEMBL2107569 0.86 ALDH2 (0.57) ALDH2MAOAMAOB
SCHEMBL2110442 0.86 ALDH2 (0.41) ALDH2MAOAMAOB
SCHEMBL2106844 0.85 ALDH2 (0.64) ALDH2MAOAMAOB
SCHEMBL2107541 0.85 ALDH2 (0.42) ALDH2MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2254878-A1 ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION Gilead Palo Alto, Inc. (US) 2010-12-01 EP disclosed
EP-2231149-A2 ALDH-2 INHIBITORS IN THE TREATMENT OF PSYCHIATRIC DISORDERS CV Therapeutics Inc. (US) 2010-09-29 EP disclosed
WO-2009094028-A1 ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION CV THERAPEUTICS, INC. (US) 2009-07-30 WO disclosed
WO-2009061924-A2 ALDH-2 INHIBITORS IN THE TREATMENT OF PSYCHIATRIC DISORDERS CV THERAPEUTICS, INC. (US) 2009-05-14 WO disclosed
EP-2046769-A2 ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION CV THERAPEUTICS, INC. (US) 2009-04-15 EP disclosed
WO-2008014497-A2 ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION CV THERAPEUTICS, INC. (US) 2008-01-31 WO disclosed